Gastrointestinal tolerability and effectiveness of rofecoxib versus naproxen in the treatment of osteoarthritis: a randomized, controlled trial.Show others and affiliations
2003 (English)In: Ann Intern Med, ISSN 1539-3704, Vol. 139, no 7, p. 539-46Article in journal (Other scientific) Published
Place, publisher, year, edition, pages
2003. Vol. 139, no 7, p. 539-46
Keywords [en]
Anti-Inflammatory Agents; Non-Steroidal/*adverse effects/therapeutic use, Aspirin/therapeutic use, Cardiovascular Diseases/complications, Comparative Study, Cyclooxygenase Inhibitors/*adverse effects/therapeutic use, Double-Blind Method, Drug Therapy; Combination, Female, Gastrointestinal Diseases/*chemically induced, Humans, Hypertension/complications, Lactones/*adverse effects/therapeutic use, Male, Middle Aged, Naproxen/*adverse effects/therapeutic use, Osteoarthritis/complications/*drug therapy, Prospective Studies, Research Support; Non-U.S. Gov't, Sulfones
Identifiers
URN: urn:nbn:se:uu:diva-83148PubMedID: 14530224OAI: oai:DiVA.org:uu-83148DiVA, id: diva2:111055
2006-10-192006-10-192011-01-13